A retrospective, qualitative cohort study concludes that patients with sickle cell disease (SCD) may have been negatively impacted by the 2016 CDC guidance. The 2016 CDC Guideline for Opioid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback